Z. Ustuner Et Al. , "Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography," MEDICAL ONCOLOGY , vol.29, no.5, pp.3125-3128, 2012
Ustuner, Z. Et Al. 2012. Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography. MEDICAL ONCOLOGY , vol.29, no.5 , 3125-3128.
Ustuner, Z., Akay, O. M., Keskin, M., Kus, E., BAL, C., & Gulbas, Z., (2012). Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography. MEDICAL ONCOLOGY , vol.29, no.5, 3125-3128.
Ustuner, Zeki Et Al. "Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography," MEDICAL ONCOLOGY , vol.29, no.5, 3125-3128, 2012
Ustuner, Zeki Et Al. "Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography." MEDICAL ONCOLOGY , vol.29, no.5, pp.3125-3128, 2012
Ustuner, Z. Et Al. (2012) . "Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography." MEDICAL ONCOLOGY , vol.29, no.5, pp.3125-3128.
@article{article, author={Zeki Ustuner Et Al. }, title={Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography}, journal={MEDICAL ONCOLOGY}, year=2012, pages={3125-3128} }